Kan-Di-Ki LLC
Kan-Di-Ki LLC was paid $3.60M by Medicaid between Jan 2018 and Dec 2024, across 125 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 16% of everything it billed.
LAS VEGAS, NV 89128
Next to other Clinical Medical Laboratory providers in Nevada
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,211 | $95K | |
| 2019 | 76,287 | $72K | |
| 2020 | 58,679 | $80K | |
| 2021 | 162,508 | $546K | |
| 2022 | 181,003 | $778K | |
| 2023 | 228,533 | $890K | |
| 2024incomplete | 251,162 | $1.14M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16% | 174,948 | 123,725 | $575K |
| 80053 | Comprehensive metabolic panel | 13% | 99,986 | 80,266 | $465K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6.6% | 69,052 | 48,189 | $239K |
| 84443 | Thyroid stimulating hormone (TSH) | 6.4% | 29,609 | 27,833 | $230K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.3% | 13,503 | 12,909 | $225K |
| 80061 | Lipid panel | 5.2% | 28,856 | 27,770 | $188K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 4.7% | 113,596 | 64,566 | $169K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.5% | 30,943 | 29,398 | $163K |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 2.5% | 105,058 | 59,558 | $92K |
| 84134 | 2.5% | 11,549 | 10,377 | $89K | |
| 80164 | 2.5% | 13,975 | 12,497 | $89K | |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 56,737 | 32,505 | $62K |
113 more codes
| 83735 | 1.6% | 22,932 | $58K | |
| 83880 | 1.5% | 2,604 | $55K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 12,443 | $48K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 1,012 | $47K |
| 80177 | 1.2% | 5,464 | $42K | |
| 80202 | 1.2% | 7,216 | $41K | |
| 87186 | <1% | 9,372 | $36K | |
| 84439 | <1% | 8,083 | $35K | |
| 82140 | <1% | 3,973 | $32K | |
| 81001 | <1% | 25,496 | $29K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 646 | $29K |
| 82728 | <1% | 4,359 | $28K | |
| 87493 | <1% | 1,405 | $26K | |
| 80076 | <1% | 7,890 | $25K | |
| 87077 | <1% | 6,476 | $23K | |
| 82607 | <1% | 5,060 | $23K | |
| 82746 | <1% | 3,553 | $22K | |
| 85610 | <1% | 13,175 | $21K | |
| 80069 | <1% | 11,409 | $21K | |
| 83540 | <1% | 6,219 | $21K | |
| 86140 | <1% | 9,048 | $19K | |
| 83550 | <1% | 3,877 | $17K | |
| 87070 | <1% | 4,191 | $16K | |
| 84145 | <1% | 1,753 | $16K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 45,067 | $16K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,018 | $14K |
| 80185 | <1% | 2,140 | $14K | |
| 83970 | <1% | 754 | $13K | |
| 86480 | <1% | 327 | $13K | |
| 84100 | <1% | 5,393 | $12K | |
| 80159 | <1% | 1,288 | $12K | |
| 80050 | General health panel | <1% | 503 | $12K |
| 87631 | <1% | 208 | $11K | |
| 80178 | <1% | 2,718 | $10K | |
| 85652 | <1% | 9,718 | $10K | |
| 85027 | <1% | 3,467 | $9K | |
| 87040 | <1% | 1,907 | $8K | |
| 82248 | <1% | 2,538 | $8K | |
| 82274 | <1% | 1,036 | $8K | |
| 82805 | <1% | 459 | $8K | |
| 82565 | <1% | 2,728 | $7K | |
| 84481 | <1% | 812 | $6K | |
| 84436 | <1% | 1,423 | $5K | |
| 84466 | <1% | 860 | $5K | |
| 82550 | <1% | 1,429 | $4K | |
| 82040 | <1% | 1,554 | $4K | |
| 85730 | <1% | 1,201 | $4K | |
| 85018 | <1% | 4,574 | $4K | |
| 84550 | <1% | 2,040 | $4K | |
| 84460 | <1% | 1,201 | $4K | |
| 84132 | <1% | 1,896 | $3K | |
| 85014 | <1% | 3,838 | $3K | |
| 84520 | <1% | 1,508 | $3K | |
| 80162 | <1% | 574 | $3K | |
| 83690 | <1% | 665 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 182 | $2K |
| 87088 | <1% | 597 | $2K | |
| 84153 | <1% | 261 | $2K | |
| R0070 | Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen | <1% | 15 | $2K |
| 80074 | <1% | 76 | $2K | |
| 84450 | <1% | 642 | $2K | |
| 85004 | <1% | 520 | $2K | |
| 82150 | <1% | 409 | $2K | |
| 82570 | <1% | 776 | $2K | |
| 82378 | <1% | 198 | $2K | |
| 82043 | <1% | 620 | $2K | |
| 84480 | <1% | 263 | $2K | |
| 82652 | <1% | 72 | $2K | |
| 80156 | <1% | 279 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 405 | $1K |
| 86592 | <1% | 503 | $1K | |
| R0075 | Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen | <1% | 25 | $1K |
| 80184 | <1% | 241 | $1K | |
| 86703 | <1% | 86 | $939.86 | |
| 83605 | <1% | 298 | $889.63 | |
| 86803 | <1% | 106 | $865.19 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 19 | $853.73 |
| 84295 | <1% | 258 | $798.89 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 51 | $680.60 |
| 87045 | <1% | 161 | $638.13 | |
| Q0092 | Set-up portable x-ray equipment | <1% | 50 | $615.78 |
| 87340 | <1% | 72 | $605.58 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 126 | $597.93 |
| 84075 | <1% | 175 | $563.44 | |
| 86706 | <1% | 68 | $562.61 | |
| 86704 | <1% | 54 | $520.72 | |
| 85379 | <1% | 139 | $493.91 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | $438.72 |
| 84479 | <1% | 92 | $358.15 | |
| 85045 | <1% | 204 | $357.53 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 13 | $332.35 |
| 82247 | <1% | 72 | $318.57 | |
| 71045 | Radiologic examination, chest; single view | <1% | 72 | $282.25 |
| 80051 | <1% | 42 | $280.41 | |
| 83615 | <1% | 145 | $272.06 | |
| 87324 | <1% | 42 | $210.97 | |
| 84146 | <1% | 45 | $199.39 | |
| 82310 | <1% | 54 | $191.57 | |
| 80165 | <1% | 49 | $169.94 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $157.24 |
| 80173 | <1% | 15 | $136.39 | |
| 84165 | <1% | 38 | $123.65 | |
| 84156 | <1% | 88 | $115.81 | |
| 82947 | <1% | 52 | $108.95 | |
| 87101 | <1% | 16 | $104.96 | |
| 83519 | <1% | 22 | $99.87 | |
| 87220 | <1% | 49 | $91.13 | |
| 85049 | <1% | 33 | $76.41 | |
| 87205 | <1% | 50 | $72.75 | |
| 80299 | <1% | 16 | $56.06 | |
| 83516 | <1% | 15 | $32.72 | |
| 84155 | <1% | 12 | $22.56 | |
| 99199 | Unlisted special service, procedure or report | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Symphony Diagnostic Services No 1 LLC | Sparks, MD | $38.32M |
| Kan-Di-Ki LLC | North Hollywood, CA | $13.48M |
| New Schryver LLC | Denver, CO | $7.16M |
| U S Lab & Radiology LLC | Brockton, MA | $6.73M |
| Symphony Diagnostic Services No 1 LLC | Clearwater, FL | $3.22M |
| Community Mobile Diagnostics LLC | San Leandro, CA | $3.15M |
| New Schryver LLC | Denver, CO | $3.13M |
| American Diagnostics Services LLC | Windsor Mill, MD | $3.13M |
| Kan-Di-Ki, LLC | North Hollywood, CA | $784K |
| Kan-Di-Ki LLC | Tukwila, WA | $623K |
| New Schryver LLC | Carrollton, TX | $370K |
| Kan-Di-Ki LLC | Denver, CO | $289K |
| Kan-Di-Ki LLC | North Hollywood, CA | $274K |
| Kan-Di-Ki, LLC | Portland, OR | $268K |
| Kan-Di-Ki, LLC | Las Vegas, NV | $259K |
| Reono Bertagnolli a Medical Group | San Leandro, CA | $216K |
| Kan-Di-Ki, LLC | Phoenix, AZ | $144K |
| Kan Di Ki, LLC | Carrollton, TX | $92K |
| New Schryver LLC | Tukwila, WA | $83K |
| Community Mobile Ultrasound, LLC | Oceanside, CA | $73K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.